L
Lyndsay Fisher
Physician
grad_student
College of Medicine Administration
1 h-index
3 pubs
13 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Lyndsay Fisher's research focuses on critical areas within pediatric medicine, particularly concerning infections and their management in young patients. Her work includes the prospective external validation of models designed to predict bloodstream infection risk in febrile, non-neutropenic children with cancer. Fisher has also investigated unusual drivers of HLH-like syndromes, such as fatal tick-borne diseases in infants. Additionally, her research addresses the timely administration of antibiotics to febrile neutropenic patients in emergency room settings. Fisher has published three papers, with a total of 12 citations, and maintains an h-index of 1. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Kevin Bielamowicz, Salim Aljabari, Steven Dahl, and Hannah Wilkins.
Metrics
- h-index: 1
- Publications: 3
- Citations: 13
Selected Publications
-
828: FATAL TICK-BORNE DISEASE IN A VERY YOUNG INFANT: AN UNUSUAL DRIVER OF HLH-LIKE SYNDROME (2023)
-
Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer (2023)
-
Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room (2023)
Collaboration Network
Top Collaborators
JM Mack
University of Arkansas for Medical Sciences
1 shared publication
In database
- Reducing the time of antibiotic administration to febrile neutropenic patients in the emergency room
Zhiguo Zhao
Vanderbilt University Medical Center (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Pratik A. Patel
Children's Healthcare of Atlanta (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Leonora R. Slatnick
University of Colorado Denver (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Anna Sitthi-Amorn
St. Jude Children's Research Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Kevin Bielamowicz
Arkansas Children's Hospital
1 shared publication
In database
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Farranaz A. Nunez
Arkansas Children's Hospital
1 shared publication
In database
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Alexandra Walsh
Phoenix Children's Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Jennifer Hess
Phoenix Children's Hospital (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Jenna Rossoff
Northwestern University (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Caitlin W. Elgarten
Children's Hospital of Philadelphia (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Regina M. Myers
Children's Hospital of Philadelphia (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Raya Saab
American University of Beirut Medical Center (LB)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Maya Basbous
American University of Beirut Medical Center (LB)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Meghan McCormick
University of Pittsburgh Medical Center (US)
1 shared publication
- Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer
Similar Researchers
Based on overlapping research topics
Mary Anderson Wallace
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Emergency and Acute Care Studies
Matthew Samaro
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Emergency and Acute Care Studies
Rashmitha Dachepally
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Emergency and Acute Care Studies
Michael Saccente
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Emergency and Acute Care Studies
Salim Aljabari
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Emergency and Acute Care Studies
David White
University of Arkansas for Medical Sciences
Child and Adolescent Health
Microbial infections and disease research
Healthcare Policy and Management